D Dimer Testing Market Size, Share, and Trends Report by Product Category

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

How Does the Projected Market Size of the D Dimer Testing Market Compare to 2026 Levels?
The d dimer testing market size has grown strongly in recent years. It will grow from $1.54 billion in 2025 to $1.62 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to high incidence of thrombotic disorders, hospital-based laboratory testing, reliance on elisa methods, emergency diagnostic demand, limited rapid testing access.

The d dimer testing market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to growth of point-of-care diagnostics, increasing cardiovascular disease burden, technological advancements in immunoassays, faster turnaround demand, expansion of decentralized testing. Major trends in the forecast period include rising adoption of point-of-care testing, increased use in emergency diagnostics, expansion of automated laboratory analyzers, growth of rapid testing kits, integration into clinical decision protocols.

Claim your free report sample now:
D Dimer Testing Market Growth, Size Report 2026 to 2035 Sample

Which Major Growth Drivers Will Influence the D Dimer Testing Market by 2030?
The increasing prevalence of cancer is expected to propel the growth of the d-dimer testing market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. D-dimer testing is primarily used to help diagnose, monitor, and treat cancer patients and assess the risk of blood clot formation. It monitors thrombotic events in various clinical settings. For instance, in May 2025, according to the National Cancer Institute (NCI), a US-based government agency dedicated to cancer research and education, in 2025 an estimated 2,041,910 new cases of cancer will be diagnosed in the United States, and 618,120 people will die from the disease. Among men, prostate, lung, and colorectal cancers are expected to account for approximately 48% of all new cancer diagnoses, while among women, breast, lung, and colorectal cancers will account for about 51% of all new cases. In addition, an estimated 14,690 children and adolescents ages 0 to 19 will be diagnosed with cancer in 2025, with 1,650 expected to die from the disease. Therefore, the increasing prevalence of cancer is driving the growth of the d-dimer testing market.

How Is the D Dimer Testing Market Segmented?
The d dimer testing market covered in this report is segmented –

1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests
2) By Product: Analyzers, Reagents And Consumables
3) By Method: Enzyme-Linked Immunosorbent Assay (ELISA), Latex-Enhanced Immuno-Turbidimetric Assays, Fluorescence Immunoassays, Other Testing Methods
4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Applications
5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-Users

Subsegments:
1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays
2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays

Which Trends Are Most Likely to Influence D Dimer Testing Market Growth in the Next Decade?
Major companies operating in the d-dimer testing market are developing innovative products, such as D-dimer test kit, to improve the accuracy and speed of diagnosing blood clot-related conditions. A D-dimer test kit is a medical diagnostic tool used to measure the levels of D-dimer, a fibrin degradation product, in the blood, which helps in assessing the presence of blood clots and conditions such as deep vein thrombosis, pulmonary embolism, or disseminated intravascular coagulation. For instance, in July 2024, Bionote Inc., a South Korea-based medical equipment manufacturing company launched Vcheck D-dimer 5Tests/Kit. A new D-dimer 5-Test Kit for Vcheck immunodiagnostic equipment has been launched, specifically designed for veterinary clinics. This kit aids in diagnosing conditions such as thrombosis and DIC, making it ideal for smaller clinics with fewer emergency cases.

Which Organizations Are Key Contributors to the D Dimer Testing Market?
Major companies operating in the d dimer testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

Get the full d dimer testing market report here:
https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

How does market performance vary across key regions in the D Dimer Testing Market?
North America was the largest region in the D dimer testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the d dimer testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

#Contact Us:#

The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

#Follow Us On:#

LinkedIn: The Business Research Company | LinkedIn